Endurant Capital Management LP Qiagen N.V. Transaction History

Endurant Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$35.55 - $43.57 $2.04 Million - $2.5 Million	-57,489 Reduced 91.68%	5,219 $226,000
Q2 2023 Aug 14, 2023	SELL	$43.93 - $46.76 $5.1 Million - $5.43 Million	-116,186 Reduced 64.95%	62,708 $2.82 Million
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $6.26 Million - $7.01 Million	138,145 Added 339.01%	178,894 $8.22 Million
Q4 2022 Feb 14, 2023	SELL	$41.91 - $50.48 $11 Million - $13.3 Million	-263,179 Reduced 86.59%	40,749 $2.03 Million
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $3.86 Million - $4.75 Million	-94,293 Reduced 23.68%	303,928 $12.5 Million

Q2 2022 Aug 15, 2022	BUY	$42.98 - $49.77 $14.7 Million - $17 Million	342,565 Added 615.5%	398,221 $18.8 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $2.35 Million - $3.02 Million	55,656 New	55,656 $2.73 Million
Q2 2018 Aug 14, 2018	SELL	$31.23 - $37.47 $640,215 - $768,135	-20,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$31.01 - $34.72 $635,705 - $711,760	20,500 New	20,500 $662,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.